Determining the incidence of aspergillosis after liver transplant

Experimental and Clinical Transplantation

Volumn 8, Issue 3, 2010, Pages 220-223

  Badiee, Parisa ^a   Alborzi, Abdolvahab ^a   Malekhosseini, Seyed Ali ^b   Nikeghbalian, Saman ^b   Shakiba, Elaheh ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

A. flavus; A. fumigatus; Fungal infection; Nested PCR

Indexed keywords

ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; FEMALE; FUNGAL DETECTION; FUNGUS CULTURE; GRAFT RECIPIENT; HUMAN; INVASIVE ASPERGILLOSIS; IRAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEX RATIO; TEACHING HOSPITAL;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; ASPERGILLUS; CHILD; CHILD, PRESCHOOL; DNA, FUNGAL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALS, TEACHING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT; INVASIVE PULMONARY ASPERGILLOSIS; IRAN; LENGTH OF STAY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RIBOTYPING; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77957143576     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Fortún J, Martín-Dávila P, Moreno S, et al. Risk factors for invasive aspergillosis in liver transplant recipients. Liver Transpl. 2002;8(11):1065-1070.
2. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005;18(1):44-69.
3. Dunn DL. Hazardous crossing: immunosuppression and nosocomial infections in solid organ transplant recipients. Surg Infect (Larchmt). 2001;2(2):103-110; discussion 110-112.
4. Ergin F, Arslan H, Azap A, Demirhan B, Karakayali H, Haberal M. Invasive aspergillosis in solid-organ transplantation: report of eight cases and review of the literature. Transpl Int. 2003;16(4):280-286.
5. Paya CV. Prevention of fungal infection in transplantation. Transpl Infect Dis. 2002;4(suppl 3):46-51.
6. Yamakami Y, Hashimoto A, Tokimatsu I, Nasu M. PCR detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis. J Clin Microbiol. 1996;34(10):2464-2468.
7. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813-1821.
8. Pappas PG, Andes D, Schuster M, et al. Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. Am J Transplant. 2006;6(2):386-391.
9. Fung JJ. Fungal infection in liver transplantation. Transpl Infect Dis. 2002;4 (suppl 3):18-23.
10. Fishman JA. Overview: fungal infections in the transplant patient. Transpl Infect Dis. 2002;4(suppl 3):3-11.
11. Loeffler J, Kloepfer K, Hebart H, et al. Polymerase chain reaction detection of aspergillus DNA in experimental models of invasive aspergillosis. J Infect Dis. 2002;185(8):1203-1206.
12. Buchheidt D, Baust C, Skladny H, et al. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis. 2001;33(4):428-435.
13. Badiee P, Kordbacheh P, Alborzi A, et al. Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections. Liver Transpl. 2007;13(7):1011-1016.
14. Badiee P, Kordbacheh P, Alborzi A, Malekhoseini SA. Invasive fungal infection in renal transplant recipients demonstrated by panfungal polymerase chain reaction. Exp Clin Transplant. 2007;5(1):624-629.
15. Hebart H, Bollinger C, Fisch P, et al. Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood. 2002;100(13):4521-4528.
16. Fortún J, Martín-Davila P, Moreno S, et al. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J Antimicrob Chemother. 2003;52(5):813-819.
17. Busuttil RW, Farmer DG, Yersiz H, et al. Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg. 2005;241(6):905-916; discussion 916-918.
18. Teisseyre J, Kalicinski P, Markiewicz-Kijewska M, et al. Aspergillosis in children after liver transplantation: Single center experience. Pediatr Transplant. 2007;11(8):868-875.
19. Verma A, Wade JJ, Cheeseman P, et al. Risk factors for fungal infection in paediatric liver transplant recipients. Pediatr Transplant. 2005;9(2):220-225.
20. Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26(4):781-803; quiz 804-805.
21. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev. 2005;18(1):44-69.